OTHER · Unmapped registry intervention
eMRI/MRSI
Find medicine records ·
Find other trials using this name
Clinical trial
MRI/MRSI in Risk Assessment of Prostate Cancer Patients
NCT00582543
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedMRI/MRSI in Risk Assessment of Prostate Cancer Patients
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
eMRI/MRSIOTHER
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
National Institutes of Health (NIH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00582543 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.